Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1992 Jul;66(1):106–112. doi: 10.1038/bjc.1992.225

Overexpression of multiple oncogenes related to histological grade of astrocytic glioma.

J M Orian 1, K Vasilopoulos 1, S Yoshida 1, A H Kaye 1, C W Chow 1, M F Gonzales 1
PMCID: PMC1977917  PMID: 1322154

Abstract

The expression of the c-erbB-1, c-myc, Ha/N-ras and c-fos oncogenes was investigated in 62 astrocytomas of low, intermediate and high grades by immunogold silver histochemistry. Elevated expression of c-erbB-1 was observed in 95%, 48% and 86% of low, intermediate and high grade tumours respectively, c-myc in 5%, 33% and 76% respectively, Ha/N-ras in 0, 43% and 71% respectively and c-fos in 55%, 48% and 52% respectively. Controls included normal brain and tumour sections immunoreacted with pre-immune serum or with antisera absorbed with synthetic peptides. Analysis of co-overexpression revealed that low grade tumours co-overexpressed a maximum of two of these genes, intermediate grade tumours a maximum of three of these genes, while co-overexpression of all four genes was observed in some high grade tumours. Co-overexpression of c-erbB-1 and c-fos was frequently observed in low grade astrocytomas and may be predictive of non-progression. On the other hand, there was a statistically significant increase in the number of tumours overexpressing Ha/N-ras or c-myc with increasing grade of tumour, suggesting that overexpression of these two oncogenes may be indicative of progression.

Full text

PDF
106

Images in this article

108Figure 1
on p.108
110Figure 2
on p.110

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartram C. R., Berthold F. Amplification and expression of the N-myc gene in neuroblastoma. Eur J Pediatr. 1987 Mar;146(2):162–165. doi: 10.1007/BF02343225. [DOI] [PubMed] [Google Scholar]
  2. Blin N., Müller-Brechlin R., Carstens C., Meese E., Zang K. D. Enhanced expression of four cellular oncogenes in a human glioblastoma cell line. Cancer Genet Cytogenet. 1987 Apr;25(2):285–292. doi: 10.1016/0165-4608(87)90189-0. [DOI] [PubMed] [Google Scholar]
  3. Borg A., Linell F., Idvall I., Johansson S., Sigurdsson H., Fernö M., Killander D. HER2/neu amplification and comedo type breast carcinoma. Lancet. 1989 Jun 3;1(8649):1268–1269. doi: 10.1016/s0140-6736(89)92365-9. [DOI] [PubMed] [Google Scholar]
  4. Brodeur G. M. Neuroblastoma--clinical applications of molecular parameters. Brain Pathol. 1990 Sep;1(1):47–54. doi: 10.1111/j.1750-3639.1990.tb00638.x. [DOI] [PubMed] [Google Scholar]
  5. Cole M. D. The myc oncogene: its role in transformation and differentiation. Annu Rev Genet. 1986;20:361–384. doi: 10.1146/annurev.ge.20.120186.002045. [DOI] [PubMed] [Google Scholar]
  6. Curran T., Miller A. D., Zokas L., Verma I. M. Viral and cellular fos proteins: a comparative analysis. Cell. 1984 Feb;36(2):259–268. doi: 10.1016/0092-8674(84)90219-8. [DOI] [PubMed] [Google Scholar]
  7. Curran T., Van Beveren C., Verma I. M. Viral and cellular fos proteins are complexed with a 39,000-dalton cellular protein. Mol Cell Biol. 1985 Jan;5(1):167–172. doi: 10.1128/mcb.5.1.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dalla-Favera R., Cesarman E. Cellular oncogenes and the pathogenesis of human cancer. Horiz Biochem Biophys. 1986;8:503–544. [PubMed] [Google Scholar]
  9. Engelhard H. H., 3rd, Butler A. B., 4th, Bauer K. D. Quantification of the c-myc oncoprotein in human glioblastoma cells and tumor tissue. J Neurosurg. 1989 Aug;71(2):224–232. doi: 10.3171/jns.1989.71.2.0224. [DOI] [PubMed] [Google Scholar]
  10. Evan G. I., Hancock D. C. Studies on the interaction of the human c-myc protein with cell nuclei: p62c-myc as a member of a discrete subset of nuclear proteins. Cell. 1985 Nov;43(1):253–261. doi: 10.1016/0092-8674(85)90030-3. [DOI] [PubMed] [Google Scholar]
  11. Fujimoto M., Sheridan P. J., Sharp Z. D., Weaker F. J., Kagan-Hallet S., Story J. L. Proto-oncogene analyses in brain tumors. J Neurosurg. 1989 Jun;70(6):910–915. doi: 10.3171/jns.1989.70.6.0910. [DOI] [PubMed] [Google Scholar]
  12. Fukui M., Yamamoto T., Kawai S., Mitsunobu F., Toyoshima K. Molecular cloning and characterization of an activated human c-raf-1 gene. Mol Cell Biol. 1987 May;7(5):1776–1781. doi: 10.1128/mcb.7.5.1776. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Garson J. A., McIntyre P. G., Kemshead J. T. N-myc amplification in malignant astrocytoma. Lancet. 1985 Sep 28;2(8457):718–719. doi: 10.1016/s0140-6736(85)92950-2. [DOI] [PubMed] [Google Scholar]
  14. Gerosa M. A., Talarico D., Fognani C., Raimondi E., Colombatti M., Tridente G., De Carli L., Della Valle G. Overexpression of N-ras oncogene and epidermal growth factor receptor gene in human glioblastomas. J Natl Cancer Inst. 1989 Jan 4;81(1):63–67. doi: 10.1093/jnci/81.1.63. [DOI] [PubMed] [Google Scholar]
  15. Hawkins R. A., Killen E., Whittle I. R., Jack W. J., Chetty U., Prescott R. J. Epidermal growth factor receptors in intracranial and breast tumours: their clinical significance. Br J Cancer. 1991 Apr;63(4):553–560. doi: 10.1038/bjc.1991.130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Henn W., Blin N., Zang K. D. Polysomy of chromosome 7 is correlated with overexpression of the erbB oncogene in human glioblastoma cell lines. Hum Genet. 1986 Sep;74(1):104–106. doi: 10.1007/BF00278796. [DOI] [PubMed] [Google Scholar]
  17. Holgate C. S., Jackson P., Cowen P. N., Bird C. C. Immunogold-silver staining: new method of immunostaining with enhanced sensitivity. J Histochem Cytochem. 1983 Jul;31(7):938–944. doi: 10.1177/31.7.6189883. [DOI] [PubMed] [Google Scholar]
  18. Hunter T. Cooperation between oncogenes. Cell. 1991 Jan 25;64(2):249–270. doi: 10.1016/0092-8674(91)90637-e. [DOI] [PubMed] [Google Scholar]
  19. Kinzler K. W., Bigner S. H., Bigner D. D., Trent J. M., Law M. L., O'Brien S. J., Wong A. J., Vogelstein B. Identification of an amplified, highly expressed gene in a human glioma. Science. 1987 Apr 3;236(4797):70–73. doi: 10.1126/science.3563490. [DOI] [PubMed] [Google Scholar]
  20. Kinzler K. W., Zehnbauer B. A., Brodeur G. M., Seeger R. C., Trent J. M., Meltzer P. S., Vogelstein B. Amplification units containing human N-myc and c-myc genes. Proc Natl Acad Sci U S A. 1986 Feb;83(4):1031–1035. doi: 10.1073/pnas.83.4.1031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Libermann T. A., Nusbaum H. R., Razon N., Kris R., Lax I., Soreq H., Whittle N., Waterfield M. D., Ullrich A., Schlessinger J. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature. 1985 Jan 10;313(5998):144–147. doi: 10.1038/313144a0. [DOI] [PubMed] [Google Scholar]
  22. Maguire H. C., Jr, Greene M. I. The neu (c-erbB-2) oncogene. Semin Oncol. 1989 Apr;16(2):148–155. [PubMed] [Google Scholar]
  23. Malden L. T., Novak U., Kaye A. H., Burgess A. W. Selective amplification of the cytoplasmic domain of the epidermal growth factor receptor gene in glioblastoma multiforme. Cancer Res. 1988 May 15;48(10):2711–2714. [PubMed] [Google Scholar]
  24. Marshall C. J. Tumor suppressor genes. Cell. 1991 Jan 25;64(2):313–326. doi: 10.1016/0092-8674(91)90641-b. [DOI] [PubMed] [Google Scholar]
  25. Nakagawara A., Ikeda K., Tsuda T., Higashi K., Okabe T. Amplification of N-myc oncogene in stage II and IVS neuroblastomas may be a prognostic indicator. J Pediatr Surg. 1987 May;22(5):415–418. doi: 10.1016/s0022-3468(87)80260-9. [DOI] [PubMed] [Google Scholar]
  26. RINGERTZ N. Grading of gliomas. Acta Pathol Microbiol Scand. 1950;27(1):51–64. [PubMed] [Google Scholar]
  27. Reifenberger G., Prior R., Deckert M., Wechsler W. Epidermal growth factor receptor expression and growth fraction in human tumours of the nervous system. Virchows Arch A Pathol Anat Histopathol. 1989;414(2):147–155. doi: 10.1007/BF00718594. [DOI] [PubMed] [Google Scholar]
  28. Slamon D. J., Clark G. M., Wong S. G., Levin W. J., Ullrich A., McGuire W. L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987 Jan 9;235(4785):177–182. doi: 10.1126/science.3798106. [DOI] [PubMed] [Google Scholar]
  29. Trent J., Meltzer P., Rosenblum M., Harsh G., Kinzler K., Mashal R., Feinberg A., Vogelstein B. Evidence for rearrangement, amplification, and expression of c-myc in a human glioblastoma. Proc Natl Acad Sci U S A. 1986 Jan;83(2):470–473. doi: 10.1073/pnas.83.2.470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Tsuda T., Obara M., Hirano H., Gotoh S., Kubomura S., Higashi K., Kuroiwa A., Nakagawara A., Nagahara N., Shimizu K. Analysis of N-myc amplification in relation to disease stage and histologic types in human neuroblastomas. Cancer. 1987 Aug 15;60(4):820–826. doi: 10.1002/1097-0142(19870815)60:4<820::aid-cncr2820600418>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  31. Tuzi N. L., Venter D. J., Kumar S., Staddon S. L., Lemoine N. R., Gullick W. J. Expression of growth factor receptors in human brain tumours. Br J Cancer. 1991 Feb;63(2):227–233. doi: 10.1038/bjc.1991.54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Wallner K. E., Gonzales M. F., Edwards M. S., Wara W. M., Sheline G. E. Treatment results of juvenile pilocytic astrocytoma. J Neurosurg. 1988 Aug;69(2):171–176. doi: 10.3171/jns.1988.69.2.0171. [DOI] [PubMed] [Google Scholar]
  33. Wong A. J., Bigner S. H., Bigner D. D., Kinzler K. W., Hamilton S. R., Vogelstein B. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci U S A. 1987 Oct;84(19):6899–6903. doi: 10.1073/pnas.84.19.6899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Wu J. K., Chikaraishi D. M. Differential expression of ros oncogene in primary human astrocytomas and astrocytoma cell lines. Cancer Res. 1990 May 15;50(10):3032–3035. [PubMed] [Google Scholar]
  35. Yeaton R. W., Lipari M. T., Fox C. F. Calcium-mediated degradation of epidermal growth factor receptor in dislodged A431 cells and membrane preparations. J Biol Chem. 1983 Aug 10;258(15):9254–9261. [PubMed] [Google Scholar]
  36. van de Vijver M. J., Peterse J. L., Mooi W. J., Wisman P., Lomans J., Dalesio O., Nusse R. Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer. N Engl J Med. 1988 Nov 10;319(19):1239–1245. doi: 10.1056/NEJM198811103191902. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES